What do systematic reviews say?

Adverse event outcomes for dietary combined with physical activity interventions vs information only

The review found no eligible studies for this question.

• Lifestyle changes for treating psoriasis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Prednisone plus azathioprine vs prednisone

The review found no eligible studies for this question.

• Interventions for bullous pemphigoid 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Nicotinamide plus tetracycline vs prednisone

The review found no eligible studies for this question.

• Interventions for bullous pemphigoid 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Methylprednisolone plus azathioprine vs methylprednisolone plus dapsone

The review found no eligible studies for this question.

• Interventions for bullous pemphigoid 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Clobetasol propionate cream vs prednisone

The review found no eligible studies for this question.

• Interventions for bullous pemphigoid 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Mild clobetasol propionate cream regimen (10 to 30 g/day) vs standard clobetasol propionate cream regimen (40 g/day)

The review found no eligible studies for this question.

• Interventions for bullous pemphigoid 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Neoadjuvant targeted treatment (BRAF/MEK inhibition) vs no neoadjuvant treatment

The review found no eligible studies for this question.

• Neoadjuvant treatment for stage III and IV cutaneous melanoma 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Neoadjuvant immunotherapy (talimogene laherparepvec) vs no neoadjuvant treatment

The review found no eligible studies for this question.

• Neoadjuvant treatment for stage III and IV cutaneous melanoma 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Neoadjuvant immunotherapy (combined ipilimumab and nivolumab) vs adjuvant immunotherapy (combined ipilimumab and nivolumab)

The review found no eligible studies for this question.

• Neoadjuvant treatment for stage III and IV cutaneous melanoma 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Neoadjuvant immunotherapy (combined ipilimumab and nivolumab) vs neoadjuvant immunotherapy (nivolumab)

The review found no eligible studies for this question.

• Neoadjuvant treatment for stage III and IV cutaneous melanoma 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Neoadjuvant immunotherapy (combined ipilimumab and nivolumab) vs neoadjuvant immunotherapy (sequential treatment with ipilimumab then nivolumab)

The review found no eligible studies for this question.

• Neoadjuvant treatment for stage III and IV cutaneous melanoma 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Neoadjuvant treatment vs no neoadjuvant treatment

The review found no eligible studies for this question.

• Neoadjuvant treatment for stage III and IV cutaneous melanoma 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

FAE vs MTX

• Oral fumaric acid esters for psoriasis 2015 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Finasteride vs placebo

• Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Low‐level laser comb vs Placebo (sham/placebo device)

• Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

NB‐UVB vs PUVA

The review found no eligible studies for this question.

• Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

UVA1 vs PUVA

The review found no eligible studies for this question.

• Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

NB‐UVB vs placebo

The review found no eligible studies for this question.

• Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Licochalcone‐containing moisturiser vs hydrocortisone acetate 1% cream

The review found no eligible studies for this question.

• Emollients and moisturisers for eczema 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Vehicle treatment + daily moisturiser vs fluticasone propionate twice weekly + daily moisturiser

The review found no eligible studies for this question.

• Emollients and moisturisers for eczema 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found